Search for Wyeth Corp and
  1. January 5, 2014

    Former SAC manager resolute as trial poised to start

    When prosecutors open their trial this week against Mathew Martoma, a former SAC Capital portfolio manager accused of...

  2. July 30, 2013

    Pfizer finalises overselling settlement

    Pfizer has finalised a criminal and civil settlement worth $491m with US authorities for alleged overselling of a transplant...

  1. July 5, 2013

    Scandals fuel view that foreign formula is safer

    For Wang Ya, a pigtailed 25-year-old mother pushing a pram through a Beijing supermarket, buying infant formula for her...

  2. July 3, 2013

    Baby milk makers slash prices in bow to Beijing regulators

    Baby milk manufacturers including Nestlé are to slash prices in China by up to 20 per cent to address regulators’ concerns...

  3. March 15, 2013

    SAC in record $614m insider settlements

    SAC Capital, the $15bn hedge fund run by Steven Cohen, paid $614m to settle civil insider trading charges, in what...

  4. February 13, 2013

    US authorities widen SAC Capital probe

    US authorities are expanding their investigation into potential insider trading involving SAC Capital , the $14bn hedge...

  5. FT Alphaville

    February 4, 2013

    Why do CFDs baffle the cops?

    The question is rhetorical. Back in December we were able to share a long, angry letter penned by Vincent Tchenguiz...

  6. January 3, 2013

    Ex-SAC official denies insider trading claims

    Mathew Martoma, a former portfolio manager with a unit of the hedge fund SAC Capital, has pleaded not guilty to allegations...

  7. December 2, 2012

    SAC investors face difficult choice

    Investors in SAC Capital are facing a difficult choice after two weeks of high drama – their access to one of the most...

  8. November 28, 2012

    SAC told it may face insider trading charges

    SAC Capital is likely to face civil fraud charges in what authorities say is the biggest case of insider trading yet as US...

  9. November 27, 2012

    SAC chiefs to address investors’ concerns

    SAC Capital will hold a conference call with its investors Wednesday to address concerns about the hedge fund’s links to...

  10. November 23, 2012

    Doctors tread warily over insider trading

    When Yves Benhamou, a French doctor, took a flight to Boston two years ago, he ended up with a longer and less pleasant stay...

  11. November 20, 2012

    Cohen linked to $276m insider trading scheme

    US officials have linked Steven Cohen, founder of SAC Capital, one of Wall Street’s most powerful hedge funds, to an...

  12. October 12, 2012

    Reckitt keeps its gleam on acquisition talk

    Reckitt Benckiser held steady in a falling London market on Friday amid talk of potential acquisitions. The maker of Cillit...

  13. September 11, 2012

    Pfizer moves supply chain to cloud

    Over the past 18 months, Pfizer, the global pharmaceuticals giant, has completely re-engineered its complex supply chain,...

  14. June 28, 2012

    FDA clears first obesity drug in 10 years

    The US Food and Drug Administration has approved the first anti-obesity drug in more than a decade in a move that signals...

  15. May 1, 2012

    Pfizer

    A sobering exercise for any exuberant investor: take your favourite company and consider what would happen if its most...

  16. April 23, 2012

    Nestlé secures Pfizer unit with $11.8bn bid

    Nestlé is preparing to formally take control of the nutrition business of Pfizer by next year, after winning a hotly...

  17. April 10, 2012

    Wellcome backs free access to scientific papers

    The Wellcome Trust, one of the world’s largest funders of science research, is launching a service to make scientific papers...

  18. February 29, 2012

    Insider trading probe broadens to pharma stocks

    The US investigation into insider dealing on Wall Street has broadened to include trading of biotechnology and...

  19. January 25, 2012

    Pharma groups target specialised deals

    Roche sought to strengthen its position in personalised medicine with a $5.7bn hostile bid early on Wednesday for Illumina...

  20. December 20, 2011

    Deutsche Telekom does not leave empty-handed

    No party emerges from the collapse of AT&T’s $39bn deal to buy T-Mobile USA with much to celebrate. But Deutsche Telekom, at...

  21. August 5, 2011

    Pharma: does M&A hit R&D?

    Corporate acquisitions create excitement about cost synergies and cross-selling. Whether conjoined firms make better...

  22. June 27, 2011

    Discovery is running ahead of delivery

    When Pfizer, the US drugs company, announced the closure of its landmark research and development centre at Sandwich in the...

  23. June 15, 2011

    Fat pharm: mechanics of cost-cutting

    Losing weight is prudent, but seems a waste if a heart attack kills you anyway. A big justification for the mergers that...

  24. May 4, 2011

    Drug prescribing risks hindering TB treatment

    Wide variations in the tuberculosis drugs prescribed by private doctors in the developing world risk triggering intensified...

  25. March 8, 2011

    A sugared pill

    When Daniel Carlat, a psychiatrist in Massachusetts, was flown to New York with his wife by Wyeth, the “training” weekend he...

  26. February 16, 2011

    Conditional payment cure for pharma deals

    The head of Sanofi-Aventis predicted more use of conditional payments in future biotechnology takeovers, as he clinched the...

  27. February 6, 2011

    A bitter pill for future of British science

    The announcement last week that the US drug company Pfizer is to shut its UK research centre provoked much soul-searching,...

  28. February 2, 2011

    Pfizer chief’s remedy for long-term ills

    Pfizer appointed a new chief executive at the end of last year but the pledges and problems cited by Ian Read in his first...

  29. February 2, 2011

    Pfizer

    The more than 2,000 employees of Pfizer’s research facility in Sandwich, England, who helped develop Viagra and other...

  30. January 18, 2011

    GSK charge underlines regulatory fears

    GlaxoSmithKline’s £2.2bn legal provision unveiled this week increases its status as the pharmaceutical group with the...

  31. December 10, 2010

    Kindler to receive $16.5m from Pfizer

    Jeffrey Kindler, the outgoing chief executive of Pfizer, will receive $16.5m in a final settlement following his abrupt...

  32. December 8, 2010

    Searching for a growth remedy

    Ian Read, Pfizer chief New Pfizer chief executive Ian Read – the Briton in one of the most powerful jobs in the...

  33. December 6, 2010

    Pfizer/Merck

    It has been a tumultuous week for US big pharma. Just five days after Merck’s chief executive resigned unexpectedly, Pfizer...

  34. November 17, 2010

    European pharmaceuticals

    The European pharmaceuticals sector is in a whirl this week. It is symptomatic of an industry ever more alarmed by the...

  35. November 2, 2010

    Pfizer profits knocked by deal costs

    Quarterly profits at Pfizer slumped as the world’s largest pharmaceutical company by market value took significant...

  36. FT Alphaville

    October 13, 2010

    Pfizer snaps up King Pharma for $3.6bn

    Pfizer has agreed to buy King Pharmaceuticals, a maker of prescription pain treatments, for $3.6bn in cash as the world’s...

  37. October 12, 2010

    Pfizer snaps up King Pharmaceuticals for $3.6bn

    Pfizer has agreed to buy King Pharmaceuticals, a maker of prescription pain treatments, for $3.6bn in cash as the world’s...

  38. October 12, 2010

    Pfizer/King

    King Pharmaceuticals specialises in drugs that relieve pain while lessening the risk of addiction. That sounds like just...

Search for Wyeth Corp and